On behalf of The Suppliers of Parallel Imported Medicines in Finland, Copenhagen Economics has calculated the savings from Parallel Imports (PI) of pharmaceuticals in Finland for the period 2016-2020,. Based on volume and price data, we estimate the total savings from PI to be €41m over this period.

From 2016-2020, consumers saved €17m due to lower co-payments in the pharmacy sector and taxpayers saved €24m in both the pharmacy and hospital sectors due to lower prices. In addition to these total savings of €41m, we estimate that there is an additional, untapped potential of €72m in forgone savings in 2016-2020. The forgone saving could have been realised if pharmacies had always dispensed the cheapest parallel imported alternative, assuming parallel importers had been able to supply the whole market.

Learn more about the study here.

For further information, please contact Tuomas Haanperä.